VeraMorph Completes Positive Pre — IND Meeting on Oral Fulvestrant Product, Receives NIH SBIR Phase II Grant, and Names New CEO
For best results when printing this announcement, please click on link below: VeraMorph Completes Positive Pre-IND Meeting on Oral Fulvestrant Product, Receives NIH SBIR Phase II Grant, and Names New CEO Positive pre-IND meeting with the FDA in regard to the regulatory pathway for approval of the novel oral fulvestrant